Zurich, Switzerland, March 22, 2018 – DKSH, the leading Market Expansion Services provider with a focus on Asia, announced today that its shareholders voted in favor of all proposals by the Board of Directors at its 85th Ordinary General Meeting. In total 213 shareholders, corresponding to 84.8% of share capital, were present at the meeting.

The shareholders approved the Financial Statements and the Group Consolidated Financial Statements for the financial year 2017 as well as the distribution of an ordinary dividend of CHF 1.65 per share (with a total value of CHF 107.3 million). The payment will be made from March 28, 2018.

The shareholders also agreed to discharge each member of the Board of Directors and of the Senior Executive Team for the financial year 2017. The maximum compensation of the members of the Board of Directors for 2018 and of the Senior Executive Team for 2019 has been approved.

All members of the Board of Directors who stood for re-election – namely Dr. Joerg Wolle, Dr. Frank Ch. Gulich, David Kamenetzky, Adrian T. Keller, Andreas W. Keller, Robert Peugeot, Dr. Theo Siegert and Dr. Hans Christoph Tanner – were confirmed for a term of office until completion of the next Ordinary General Meeting. Furthermore, shareholders voted in favor of the proposal to elect Prof. Dr. Annette G. Köhler and Eunice-Zehnder Lai as new members of the Board of Directors. After having served on the Board of Directors for more than ten years, Rainer-Marc Frey chose not to stand for re-election. On behalf of DKSH, Dr. Joerg Wolle thanked him for his constructive and highly appreciated contributions.

In addition, Dr. Joerg Wolle was re-elected as Chairman of the Board for the same term of office.

The existing members Adrian T. Keller, Dr. Frank Ch. Gulich and Robert Peugeot as well as new member Eunice Zehnder-Lai were elected to the Nomination and Compensation Committee.

Ernst & Young Ltd., Zurich was re-appointed as DKSH’s Statutory Auditors for the financial year 2018. Ernst A. Widmer was re-elected as Independent Proxy until completion of the next Ordinary General Meeting.

DKSH’s Chairman Dr. Joerg Wolle said: ‎"DKSH’s financial performance once again exceeded the previous year’s figures and sales increased by 4.8% ‒ despite challenging conditions in some of our markets. This is the result of our long-term strategy. Very few other companies operate with such a proven and sustainable strategy as DKSH. We will diligently further develop our strategy and adjust it periodically. DKSH is well on track!‎"